Global Information
회사소개 | 문의 | 비교리스트

세계의 불임 치료제 시장(2021-2025년)

Global Infertility Drugs Market 2021-2025

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2021년 05월 상품코드 1017123
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,551,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,682,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 불임 치료제 시장(2021-2025년) Global Infertility Drugs Market 2021-2025
발행일 : 2021년 05월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 불임 치료제 시장 규모는 2021-2025년간 10억 5,000만 달러 성장하고, 예측기간 중 5%의 CAGR로 성장할 전망입니다.

시장은 생활습관병 증가, 신흥 국가의 새로운 가능성에 의해 추진되고 있습니다.

세계 불임 치료제(Infertility Drugs) 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개 벤더를 커버하는 분석을 제공합니다.

목차

  • 주요 요약
    • 시장 개요
  • 시장 상황
    • 시장 생태계
    • 밸류체인 분석
  • 시장 규모
    • 시장 정의
    • 시장 부문 분석
    • 2020년 시장 규모
    • 시장 전망 : 2020-2025년 예측
  • Five Forces 분석
    • Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁의 위협
    • 시장 상황
  • 시장 세분화 : 제품별
    • 시장 부문
    • 제품별 비교
    • 호르몬 기반 치료 : 시장 규모와 예측(2020-2025년)
    • 기타 : 시장 규모와 예측(2020-2025년)
    • 제품별 시장 기회
  • 고객 상황
  • 지역별 상황
    • 지역별 세분화
    • 지역별 비교
    • 북미 : 시장 규모와 예측(2020-2025년)
    • 유럽 : 시장 규모와 예측(2020-2025년)
    • 아시아 : 시장 규모와 예측(2020-2025년)
    • 기타 지역 : 시장 규모와 예측(2020-2025년)
    • 주요 국가
    • 지역의 시장 기회
    • 시장 추진력
    • 시장 과제
    • 시장 동향
  • 벤더 상황
    • 개요
    • 창조적 파괴 상황
  • 벤더 분석
    • 대상 벤더
    • 벤더의 시장 포지셔닝
    • Abbott Laboratories
    • AbbVie Inc.
    • Bayer AG
    • Ferring Pharmaceuticals AS
    • GlaxoSmithKline Plc
    • Merck and Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • 부록
    • 조사 범위
    • US$ 환율
    • 조사 방법
    • 약어 리스트
KSM 21.07.29

Technavio has been monitoring the infertility drugs market and it is poised to grow by USD 1.05 billion during 2021-2025, progressing at a CAGR of almost 5% during the forecast period. Our report on the infertility drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing lifestyle diseases and untapped potential in developing countries. In addition, growing lifestyle diseases is anticipated to boost the growth of the market as well.

The infertility drugs market analysis includes the product segment and geographic landscape.

Technavio's infertility drugs market is segmented as below:

By Product

  • Hormone-based therapy
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising trend of late parenthood as one of the prime reasons driving the infertility drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on infertility drugs market covers the following areas:

  • Infertility drugs market sizing
  • Infertility drugs market forecast
  • Infertility drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infertility drugs market vendors that include Abbott Laboratories, AbbVie Inc., Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck and Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi SA. Also, the infertility drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five forces analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Hormone-based therapy - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • AbbVie Inc.
    • Bayer AG
    • Ferring Pharmaceuticals AS
    • GlaxoSmithKline Plc
    • Merck and Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Hormone-based therapy - Market size and forecast 2020-2025 ($ million)
  • 24: Hormone-based therapy - Year-over-year growth 2020-2025 (%)
  • 25: Others - Market size and forecast 2020-2025 ($ million)
  • 26: Others - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: AbbVie Inc. - Overview
  • 53: AbbVie Inc. - Product and service
  • 54: AbbVie Inc. - Key offerings
  • 55: AbbVie Inc. - Key customers
  • 56: AbbVie Inc. - Segment focus
  • 57: Bayer AG - Overview
  • 58: Bayer AG - Business segments
  • 59: Bayer AG - Key offerings
  • 60: Bayer AG - Key customers
  • 61: Bayer AG - Segment focus
  • 62: Ferring Pharmaceuticals AS - Overview
  • 63: Ferring Pharmaceuticals AS - Product and service
  • 64: Ferring Pharmaceuticals AS - Key offerings
  • 65: Ferring Pharmaceuticals AS - Key customers
  • 66: Ferring Pharmaceuticals AS - Segment focus
  • 67: GlaxoSmithKline Plc - Overview
  • 68: GlaxoSmithKline Plc - Business segments
  • 69: GlaxoSmithKline Plc - Key offerings
  • 70: GlaxoSmithKline Plc - Key customers
  • 71: GlaxoSmithKline Plc - Segment focus
  • 72: Merck and Co. Inc. - Overview
  • 73: Merck and Co. Inc. - Business segments
  • 74: Merck and Co. Inc. - Key offerings
  • 75: Merck and Co. Inc. - Key customers
  • 76: Merck and Co. Inc. - Segment focus
  • 77: Merck KGaA - Overview
  • 78: Merck KGaA - Business segments
  • 79: Merck KGaA - Key offerings
  • 80: Merck KGaA - Key customers
  • 81: Merck KGaA - Segment focus
  • 82: Novartis AG - Overview
  • 83: Novartis AG - Business segments
  • 84: Novartis AG - Key offerings
  • 85: Novartis AG - Key customers
  • 86: Novartis AG - Segment focus
  • 87: Pfizer Inc. - Overview
  • 88: Pfizer Inc. - Business segments
  • 89: Pfizer Inc. - Key offerings
  • 90: Pfizer Inc. - Key customers
  • 91: Pfizer Inc. - Segment focus
  • 92: Sanofi SA - Overview
  • 93: Sanofi SA - Business segments
  • 94: Sanofi SA - Key offerings
  • 95: Sanofi SA - Key customers
  • 96: Sanofi SA - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top
전화 문의
F A Q